BULLISHWHALES
BullishWhales · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
RepublicanSenate

Thad Cochran bought AbbVie Inc (NYSE: ABBV)

Thad Cochran (R-MS), a U.S. Senator, has disclosed 3 trades in AbbVie Inc (ABBV) since 2014, 2 purchases and 1 sale, worth an estimated $73K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Thad Cochran bought $15,001 - $50,000 of AbbVie Inc (NYSE: ABBV) on February 15, 2017. Since that trade, ABBV is up +490.89% against the S&P 500 up +272.22%, an outperformance of +218.67%.

Across these filings, Thad Cochran has been a net buyer of ABBV (a buy-to-sell ratio of 2.00). The most recent disclosed ABBV transaction shown was dated March 26, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
3
Disclosed Vol
$73K
Buys
2
67%
Sells
1
33%
Buy / Sell
2.00
ratio
First → Last
2014–2018

Thad Cochran's ABBV trades vs the price

ABBV is up +490.89% since Thad Cochran bought on February 15, 2017, versus +272.22% for the S&P 500.

Performance since this trade

Price change since trade
+490.89%
S&P 500 change since trade
+272.22%
Outperformance vs S&P 500
+218.67%

All Thad Cochran ABBV trades

TradedTypeSizeReturnEst. profit
March 26, 2018SELL$67.06+269.94%
February 15, 2017BUY$41.98+490.89%+$99K
September 15, 2014BUY$36.14+586.51%+$27K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thad Cochran & ABBV trading FAQ

Is it legal for Thad Cochran to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Thad Cochran buy ABBV?

Thad Cochran disclosed a purchase of $15,001 - $50,000 of AbbVie Inc (ABBV) on February 15, 2017, according to public STOCK Act filings.

How has ABBV performed since Thad Cochran's trade?

Since Thad Cochran bought ABBV on February 15, 2017, the stock is up +490.89%, versus +272.22% for the S&P 500 over the same period, an outperformance of +218.67%.

How many times has Thad Cochran traded ABBV?

Thad Cochran has disclosed 3 ABBV trades since 2014 (2 purchases and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

BullishWhales tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Thad Cochran's ABBV tradesAll congressional filings for AbbVie IncThad Cochran's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30